Woodline Partners LP

Position in MDGL — Madrigal Pharmaceuticals, Inc.

CIK 1784547 San Francisco, CA

Position in MDGL

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$65,904,349

-$7,271,913 QoQ

Shares Held

125,899

+0.2% QoQ

Ownership

0.546%

of shares outstanding

% of Portfolio

0.25%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2022

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Woodline Partners LP holds $3,316,203,980 across 189 Biotechnology names. MDGL ranks #9 (2.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	2,506,570	$243,763,932
2	TNGX	Tango Therapeutics, Inc.	8,000,013	$167,360,271
3	PTGX	Protagonist Therapeutics, Inc	1,414,173	$149,053,834
4	RCUS	Arcus Biosciences, Inc.	3,777,798	$81,600,436
5	ALNY	Alnylam Pharmaceuticals, Inc.	243,883	$80,693,568
6	SRRK	Scholar Rock Holding Corp	1,500,470	$73,763,105
7	RYTM	Rhythm Pharmaceuticals, Inc.	758,891	$66,000,750
8	CYTK	Cytokinetics Inc	1,000,428	$65,938,209

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$65,904,349	125,899	+0.2%	Shares	Sole	2026-05-15
2025-12-31	$73,176,262	125,659	+21.0%	Shares	Sole	2026-02-17
2025-09-30	$47,630,465	103,847	-34.9%	Shares	Sole	2025-11-14
2025-06-30	$48,308,304	159,623	-49.7%	Shares	Sole	2025-08-14
2025-03-31	$105,143,332	317,433	+2.7%	Shares	Sole	2025-05-15
2024-12-31	$95,384,232	309,117	+110.2%	Shares	Sole	2025-02-14
2024-09-30	$31,215,439	147,090	+6.3%	Shares	Sole	2024-11-14
2024-06-30	$38,748,649	138,309	+602.1%	Shares	Sole	2024-08-14
2024-03-31	$5,260,688	19,700	+59.4%	Shares	Sole	2024-05-15
2023-03-31	$2,993,849	12,358	+682.6%	Shares	Sole	2023-05-15
2022-12-31	$458,304	1,579	-91.3%	Shares	Sole	2023-02-14
2022-09-30	$1,177,813	18,123	-77.9%	Shares	Sole	2022-11-14
2022-06-30	$5,882,158	82,176	—	Shares	Sole	2022-08-15
No filing history on record for this holder in this stock.